EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage

Johanna Richter iD, Amanda J Cork iD, Yvette Ong iD, Nadia Keller, Andrew J Hayes iD, Mark A Schembri iD, Amy V Jennison iD, Mark R Davies iD, Kate Schroder iD, Mark J Walker iD, Stephan Brouwer iD

mBio · 2025

DOI: 10.1128/mbio.03366-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Johanna Richter und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Bacterial Proteins, Streptococcus pyogenes, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, DHAC | National Health and Medical Research Council (NHMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group A Streptococcus (GAS) is a human-adapted pathogen responsible for a variety of diseases. The GAS M1 UK lineage has contributed significantly to the recently reported increases in scarlet fever and invasive infections. However, the basis for its evolutionary success is not yet fully understood. During the transition to systemic disease, the M1 serotype is known to give rise to spontaneous mutations in the control of virulence two-component regulatory system (CovRS) that confer a fitness advantage during invasive infections. Mutations that inactivate CovS function result in the de-repression of key GAS virulence factors such as streptolysin O (SLO), a pore-forming toxin and major trigger of inflammasome/interleukin-1β-dependent inflammation. Conversely, expression of the streptococcal cysteine protease SpeB, which is required during initial stages of colonization and onset of invasive disease, is typically lost in such mutants. In this study, we identified and characterized a novel covS single nucleotide polymorphism detected in three separate invasive M1 UK isolates. The resulting CovS Ala318Val mutation caused a significant upregulation of SLO resulting in increased inflammasome activation in human THP-1 macrophages, indicating an enhanced inflammatory potential. Surprisingly, SpeB production was unaffected. Site-directed mutagenesis was performed to assess the impact of this mutation on virulence and global gene expression. We found that the CovS Ala318Val mutation led to subtle, virulence-specific changes of the CovRS regulon compared to previously characterized covS mutations, highlighting an unappreciated level of complexity in CovRS-dependent gene regulation. Continued longitudinal surveillance is warranted to determine whether this novel covS mutation will expand in the M1 UK lineage. IMPORTANCE The M1 UK lineage of GAS has contributed to a recent global upsurge in scarlet fever and invasive infections. Understanding how GAS can become more virulent is critical for infection control and identifying new treatment approaches. The two-component CovRS system, comprising the sensor kinase CovS and transcription factor CovR, is a central regulator of GAS virulence genes. In the M1 serotype, covRS mutations are associated with an invasive phenotype. Such mutations have not been fully characterized in the M1 UK lineage. This study identified a novel covS mutation in invasive Australian M1 UK isolates that resulted in a more nuanced virulence gene regulation compared to previously characterized covS mutations. A representative isolate displayed upregulated SLO production and triggered amplified interleukin-1β secretion in infected human macrophages, indicating an enhanced inflammatory potential. These findings underscore the need for comprehensive analyses of covRS mutants to fully elucidate their contribution to M1 UK virulence and persistence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial ProteinsStreptococcus pyogenesPolymorphism, Single NucleotideHumansStreptococcal InfectionsInflammasomesVirulence FactorsMacrophagesAustraliaTHP-1 CellsStreptolysinsGene Expression Regulation, BacterialVirulenceMutationExotoxinsHistidine Kinase

Stichwörter der Autor:innen

CovRSSLOSNPSpeBStreptococcus pyogenesinflammationinterleukin-1βtranscriptional regulationtwo-component system

Substanzen

Bacterial ProteinsInflammasomesVirulence FactorsCovS protein, Streptococcus pyogenesStreptolysinsstreptolysin OExotoxinsHistidine Kinase

Autor:innen und Institutionen

  • Institute for Molecular Bioscience, Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, Australia.
  • School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia.
  • Public and Environmental Health, Pathology Queensland, Queensland Health, Coopers Plains, Queensland, Australia.
  • Institute for Molecular Bioscience, Centre for Inflammation and Disease Research, The University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Johanna Richter, Amanda J Cork, Yvette Ong, Andrew J Hayes, Mark A Schembri, Amy V Jennison, Mark R Davies, Kate Schroder, Mark J Walker, Stephan Brouwer

Förderung

  • NIAID NIH HHS
  • DHAC | National Health and Medical Research Council (NHMRC)

Zitieren

APA

Richter, J., Cork, A. J., Ong, Y., Keller, N., Hayes, A. J., Schembri, M. A., Jennison, A. V., Davies, M. R., Schroder, K., Walker, M. J., & Brouwer, S. (2025). Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio. https://doi.org/10.1128/mbio.03366-24

Vancouver

Richter J, Cork AJ, Ong Y, Keller N, Hayes AJ, Schembri MA, et al. Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio. 2025. doi:10.1128/mbio.03366-24

BibTeX
@article{Richter2025,
  author = {Richter, Johanna and Cork, Amanda J and Ong, Yvette and Keller, Nadia and Hayes, Andrew J and Schembri, Mark A and Jennison, Amy V and Davies, Mark R and Schroder, Kate and Walker, Mark J and Brouwer, Stephan},
  title = {Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.03366-24}
}
Kostenlos starten →